Zentek Ltd. (ZTEK)
Market Closed
11 Jun, 20:00
$
0. 44
-0.03
-5.6187%
Pre Market
$
+0.06 +14.2695% 0. 50
78.32M Market Cap
- P/E Ratio
- Div Yield
103,628 Volume
0 Eps
$ 0.47
Previous Close Want to track ZTEK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
ZTEK closed today lower at $0.44, a decrease of -5.6187% from yesterday's close, completing a monthly increase of 2.3488% or $0.01. Over the past 12 months, ZTEK stock lost -33.217%.
ZTEK is not paying dividends to its shareholders.
The last earnings report, released on Feb 17, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on TSX-V (CAD).
Zentek Ltd. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| MA Marie-Andree Alain Federation des caisses Desjardins du Quebec | 151,650 | $430,343.34 | $68,242.5 | -$362,100.84 | -84.14% |
| AFI Aviso Financial Inc. Aviso Financial Inc. | 3,000 | $2,285 | $1,350 | -$935 | -40.92% |
Zentek Ltd. (ZTEK) FAQ
What is the stock price today?
The current price is $0.44.
On which exchange is it traded?
Zentek Ltd. is listed on NASDAQ (CM).
What is its stock symbol?
The ticker symbol is ZTEK.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 78.32M.
Has Zentek Ltd. ever had a stock split?
No, there has never been a stock split.
Zentek Ltd. Profile
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Mohammed Jiwan CEO | NASDAQ (CM) Exchange | 98942X102 CUSIP |
| CA Country | 24 Employees | - Last Dividend | - Last Split | 2 Apr 2012 IPO Date |
Overview
Zentek Ltd. is a Canadian company focused on the research and development of graphene and related nanomaterials. Founded in 2008 and headquartered in Thunder Bay, Canada, the company originally operated under the name ZEN Graphene Solutions Ltd. before rebranding to Zentek Ltd. in October 2021. It is primarily known for its ownership of the Albany Graphite project in Northern Ontario, which serves as a cornerstone for its extensive work in developing advanced materials and solutions. Zentek's field of expertise includes the creation of innovative products leveraging the unique properties of graphene, from antimicrobial coatings to rapid detection diagnostics and pharmaceuticals.
Products and Services
- ZenGUARD Antimicrobial Coating: A graphene-based coating developed to provide antimicrobial protection. This coating is advanced technology leveraged in various applications to prevent the growth of harmful bacteria and viruses on surfaces.
- Surgical Masks: Utilizing the antimicrobial and barrier properties of graphene, Zentek has developed surgical masks that offer enhanced protection compared to standard options. These masks are designed to be more effective in filtering pathogens, thereby providing improved safety for healthcare workers and the public.
- HVAC Filters: Heating, Ventilation, and Air Conditioning (HVAC) filters enhanced with graphene technology. These filters are designed to significantly improve air quality by effectively capturing and neutralizing airborne pollutants and pathogens, making environments safer and cleaner.
- Personal Protective Equipment (PPE): Zentek applies its graphene-based technologies to create various types of personal protective equipment, aimed at offering superior protection, durability, and effectiveness compared to traditional PPE materials.
- Rapid Detection Point of Care Diagnostic Tests: Leveraging graphene's electrical properties, Zentek has developed rapid diagnostics tests that can swiftly detect various pathogens, including viruses, at the point of care, expediting the diagnosis process and enhancing patient care.
- Pharmaceutical Products: Exploring the biomedical applications of graphene, Zentek is involved in the development of pharmaceutical products that incorporate graphene-based compounds, aiming to offer novel treatments and drug delivery methods.
- Graphene Production: In addition to product development, Zentek is involved in the synthesis of graphene, graphene oxide, and graphene quantum dots. These materials are crucial for the wide range of applications of graphene, underpinning the company's product innovations and services.
Contact Information
Address: 1205 Amber Drive
Phone: 844 730 9822
Website: https://www.zentek.com
